Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structural basis for broad coronavirus neutralization
Maximilian M. Sauer, M. Alejandra Tortorici, Young‐Jun Park, et al.
Nature Structural & Molecular Biology (2021) Vol. 28, Iss. 6, pp. 478-486
Open Access | Times Cited: 195

Showing 1-25 of 195 citing articles:

SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape
Tyler N. Starr, Nadine Czudnochowski, Zhuoming Liu, et al.
Nature (2021) Vol. 597, Iss. 7874, pp. 97-102
Open Access | Times Cited: 493
SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern
Matthew McCallum, Jessica Bassi, Anna De Marco, et al.
Science (2021) Vol. 373, Iss. 6555, pp. 648-654
Open Access | Times Cited: 439
Broad betacoronavirus neutralization by a stem helix–specific human antibody
Dora Pinto, Maximilian M. Sauer, Nadine Czudnochowski, et al.
Science (2021) Vol. 373, Iss. 6559, pp. 1109-1116
Open Access | Times Cited: 351
Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variants
Matthew McCallum, Alexandra C. Walls, Kaitlin R. Sprouse, et al.
Science (2021) Vol. 374, Iss. 6575, pp. 1621-1626
Open Access | Times Cited: 285
High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape
Fabian Schmidt, Yiska Weisblum, Magdalena Rutkowska, et al.
Nature (2021) Vol. 600, Iss. 7889, pp. 512-516
Open Access | Times Cited: 217
Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy
Irfan Ullah, Jérémie Prévost, Mark S. Ladinsky, et al.
Immunity (2021) Vol. 54, Iss. 9, pp. 2143-2158.e15
Open Access | Times Cited: 193
Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes
Jasmin Quandt, Alexander Muik, Nadine Salisch, et al.
Science Immunology (2022) Vol. 7, Iss. 75
Open Access | Times Cited: 187
Broadly neutralizing antibodies target the coronavirus fusion peptide
Cherrelle Dacon, Courtney Tucker, Linghang Peng, et al.
Science (2022) Vol. 377, Iss. 6607, pp. 728-735
Open Access | Times Cited: 187
Innate immunity at the crossroads of healthy brain maturation and neurodevelopmental disorders
Kristine E. Zengeler, John R. Lukens
Nature reviews. Immunology (2021) Vol. 21, Iss. 7, pp. 454-468
Open Access | Times Cited: 180
Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice
David R. Martinez, Alexandra Schäfer, Sarah R. Leist, et al.
Science (2021) Vol. 373, Iss. 6558, pp. 991-998
Open Access | Times Cited: 177
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
Alexandra C. Walls, Marcos C. Miranda, Alexandra Schäfer, et al.
Cell (2021) Vol. 184, Iss. 21, pp. 5432-5447.e16
Open Access | Times Cited: 161
A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection
Pan-Pan Zhou, Meng Yuan, Ge Song, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 637
Open Access | Times Cited: 160
SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity
Michael Joyce, Wei‐Hung Chen, Rajeshwer S. Sankhala, et al.
Cell Reports (2021) Vol. 37, Iss. 12, pp. 110143-110143
Open Access | Times Cited: 149
Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry
Young‐Jun Park, Anna De Marco, Tyler N. Starr, et al.
Science (2022) Vol. 375, Iss. 6579, pp. 449-454
Open Access | Times Cited: 141
ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies
Jun Siong Low, Josipa Jerak, M. Alejandra Tortorici, et al.
Science (2022) Vol. 377, Iss. 6607, pp. 735-742
Open Access | Times Cited: 139
ScanNet: an interpretable geometric deep learning model for structure-based protein binding site prediction
Jérôme Tubiana, Dina Schneidman‐Duhovny, Haim J. Wolfson
Nature Methods (2022) Vol. 19, Iss. 6, pp. 730-739
Open Access | Times Cited: 131
Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concern
Wenwei Li, Yaozong Chen, Jérémie Prévost, et al.
Cell Reports (2021) Vol. 38, Iss. 2, pp. 110210-110210
Open Access | Times Cited: 122
Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease
Pan-Pan Zhou, Ge Song, Hejun Liu, et al.
Immunity (2023) Vol. 56, Iss. 3, pp. 669-686.e7
Open Access | Times Cited: 113
Neutralization mechanism of a human antibody with pan-coronavirus reactivity including SARS-CoV-2
Xiaoyu Sun, Chunyan Yi, Yuanfei Zhu, et al.
Nature Microbiology (2022) Vol. 7, Iss. 7, pp. 1063-1074
Open Access | Times Cited: 110
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies
Claudia A. Jette, Alexander A. Cohen, Priyanthi N.P. Gnanapragasam, et al.
Cell Reports (2021) Vol. 36, Iss. 13, pp. 109760-109760
Open Access | Times Cited: 102
Close relatives of MERS-CoV in bats use ACE2 as their functional receptors
Qing Xiong, Lei Cao, Chengbao Ma, et al.
Nature (2022) Vol. 612, Iss. 7941, pp. 748-757
Open Access | Times Cited: 100
SARS-CoV-2 S2–targeted vaccination elicits broadly neutralizing antibodies
Kevin W. Ng, Nikhil Faulkner, Katja Finsterbusch, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 655
Open Access | Times Cited: 84
Antiviral Drug Discovery for the Treatment of COVID-19 Infections
Teresa I. Ng, Ivan Correia, Jane Seagal, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 961-961
Open Access | Times Cited: 77
SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccines
John E. Bowen, Young‐Jun Park, Cameron Stewart, et al.
Science Immunology (2022) Vol. 7, Iss. 78
Open Access | Times Cited: 70
Identification of a conserved S2 epitope present on spike proteins from all highly pathogenic coronaviruses
Rui P. Silva, Yimin Huang, Annalee W. Nguyen, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 64
Page 1 - Next Page

Scroll to top